Loading insider details...
Latest Form 4 (May 22, 2026): Exercise/Conversion of 9,263 MRNA shares, $177.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 22, 2026 | Moderna, Inc. (MRNA) | Exercise/Conversion | 9,263 | $177.4K |
| May 8, 2026 | Moderna, Inc. (MRNA) | Grant/Award | 12,908 | n/a |
| Mar 2, 2026 | Generate Biomedicines, Inc. (GENB) | Conversion | 12,723,940 | n/a |
| Mar 2, 2026 | Generate Biomedicines, Inc. (GENB) | Conversion | 12,723,940 | n/a |
| Jan 15, 2026 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 2,235,468 | $15.00M |
| Dec 15, 2025 | Moderna, Inc. (MRNA) | Exercise/Conversion | 23,853 | $260.0K |
| May 1, 2025 | Moderna, Inc. (MRNA) | Grant/Award | 25,512 | n/a |
| Aug 2, 2024 | Moderna, Inc. (MRNA) | Sale | 4,599 | $547.1K |
| Jul 26, 2024 | Moderna, Inc. (MRNA) | Sale | 2,668 | $310.4K |
| Jul 19, 2024 | Moderna, Inc. (MRNA) | Sale | 2,601 | $314.3K |